Antiviral drugs can be used for the treatment of influenza and the prevention of seasonal and post-exposure influenza. Four antiviral drugs are available for the prevention and treatment of ...

A virus originally found in animals, mpox -- which causes the disease of the same name -- is now circulating in humans. Since 2022, it has been the cause of major epidemics spreading outside endemic ...

Protein complex in bacterial cell membrane acts like a rotary motor to recruit DNA-degrading enzymes to defend against phage ...

A SYSTEMATIC review and meta-analysis evaluating antiviral medications for nonsevere influenza provides new insights into the optimal treatments for symptom relief and hospitalization risks, ...

Four antiviral drugs are available for the prevention and treatment of influenza infections: oseltamivir, zanamivir, rimantadine and amantadine. Oseltamivir and zanamivir are neuraminidase ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it ...

Ya Gao et al, Antiviral Medications for Treatment of Nonsevere Influenza, JAMA Internal Medicine (2025). DOI: 10.1001/jamainternmed.2024.7193 Journal information: JAMA Internal Medicine ...

Anti-inflammatory drugs like ibuprofen, along with antibiotics, antiviral medications, and vaccines, were associated with a reduced risk of dementia, according to a new systematic review.

Researchers at the Institut Pasteur have uncovered how mpox virus mutations make it resistant to tecovirimat, the primary ...

The influenza A virus (IAV) causes seasonal epidemics and occasional but devastating pandemics, which are of a major public health concern. Although several antiviral drugs are currently available, ...

This collection aims to spotlight innovative approaches and interdisciplinary efforts that are pushing the boundaries of antiviral drug discovery and vaccine development. This Research Topic aims to ...

Drug discovery is the process through which ... The SARS-CoV-2 papain-like protease inhibitor, Jun13296, displays potent oral antiviral efficacy in a mouse model of SARS-CoV-2 infection and ...